scholarly journals Drug-Resistant Malaria Parasites Introduced into Madagascar from Comoros Islands

2007 ◽  
Vol 13 (11) ◽  
pp. 1759-1762 ◽  
Author(s):  
Didier Ménard ◽  
Armand Eugène Randrianarivo-Solofoniaina ◽  
Bedja Said Ahmed ◽  
Martial Jahevitra ◽  
Landy Valérie Andriantsoanirina ◽  
...  
2006 ◽  
Vol 1 (1) ◽  
pp. 127-141 ◽  
Author(s):  
Leann Tilley ◽  
Timothy ME Davis ◽  
Patrick G Bray

Evolution ◽  
2010 ◽  
pp. no-no ◽  
Author(s):  
Silvie Huijben ◽  
William A. Nelson ◽  
Andrew R. Wargo ◽  
Derek G. Sim ◽  
Damien R. Drew ◽  
...  

The Lancet ◽  
1978 ◽  
Vol 311 (8057) ◽  
pp. 185-187 ◽  
Author(s):  
V.E. Rosario ◽  
D. Walliker ◽  
R. Hall ◽  
G.H. Beale

1975 ◽  
Vol 13 (13) ◽  
pp. 51-52

Drug resistance in the malaria parasites of man is of two kinds. The first is resistance to drugs which inhibit dihydrofolate reductase, proguanil (Paludrine) and pyrimethamine (Daraprim). This type occurs in all three common parasite species, Plasmodium falciparum, P. vivax and P. malariae. The second type of resistance is to the 4-aminoquinolines chloroquine and amodiaquine (Camoquin; Basoquin in the USA), and rarely to quinine, and this is known only in P. falciparum. Both types of resistance frequently coexist in falciparum infections.


2004 ◽  
Vol 48 (10) ◽  
pp. 3940-3943 ◽  
Author(s):  
Rachel L. Hallett ◽  
Colin J. Sutherland ◽  
Neal Alexander ◽  
Rosalynn Ord ◽  
Musa Jawara ◽  
...  

ABSTRACT Malaria parasites carrying genes conferring resistance to antimalarials are thought to have a selective advantage which leads to higher rates of transmissibility from the drug-treated host. This is a likely mechanism for the increasing prevalence of parasites with resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine in sub-Saharan Africa. Combination therapy is the key strategy being implemented to reduce the impact of resistance, but its effect on the transmission of genetically resistant parasites from treated patients to mosquito vectors has not been measured directly. In a trial comparing CQ monotherapy to the combination CQ plus artesunate (AS) in Gambian children with uncomplicated falciparum malaria, we measured transmissibility by feeding Anopheles gambiae mosquitoes with blood from 43 gametocyte-positive patients through a membrane. In the CQ-treated group, gametocytes from patients carrying parasites with the CQ resistance-associated allele pfcrt-76T prior to treatment produced infected mosquitoes with 38 times higher Plasmodium falciparum oocyst burdens than mosquitoes fed on gametocytes from patients infected with sensitive parasites (P < 0.001). Gametocytes from parasites carrying the resistance-associated allele pfmdr1-86Y produced 14-fold higher oocyst burdens than gametocytes from patients infected with sensitive parasites (P = 0.011). However, parasites carrying either of these resistance-associated alleles pretreatment were not associated with higher mosquito oocyst burdens in the CQ-AS-treated group. Thus, combination therapy overcomes the transmission advantage enjoyed by drug-resistant parasites.


2014 ◽  
Vol 31 (7) ◽  
pp. 1649-1660 ◽  
Author(s):  
Krittikorn Kümpornsin ◽  
Charin Modchang ◽  
Adina Heinberg ◽  
Eric H. Ekland ◽  
Piyaporn Jirawatcharadech ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document